- Direction
- Stable
- Own history
- 87th
- Peers
- 12th
- Persistence
- TRANSIENT
· Crude Petroleum & Natural Gas
RESEARCH SNAPSHOTArcadia Biosciences, Inc.'s latest supported as-filed period reports revenue of $1.4M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -22.11% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -0.82% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 64.45% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 43.73% · CORE
Level · gp.fundamentals.operating_margin
Raw value -34.37% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 0.00% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 0.97% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents increased 203.6%; Operating cash flow increased 84.3%.
2 evidence-backed componentsOperating cash flow changed +84.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
RKDA · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-390532SEC ↗4Sep 14, 2026Period Sep 10, 20260001193125-26-390528SEC ↗4Sep 14, 2026Period Sep 10, 20260001193125-26-390521SEC ↗4Sep 14, 2026Period Sep 10, 20260001193125-26-390520SEC ↗8-KSep 4, 2026Period Aug 31, 20260001193125-26-383642SEC ↗10-QAug 13, 2026Period Jun 30, 20260001193125-26-349205SEC ↗8-KAug 13, 2026Period Aug 13, 20260001193125-26-349180SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Cash & equivalents changed +203.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Shares outstanding changed +76.2% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Inventory changed -37.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current ratio changed -15.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed -28.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed -494 basis points from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-340664